F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom

From the publisher

The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.

The source's own excerpt, unedited